Clinical Trials Logo
  1. Home
  2. Adenomyosis
  3. NCT03428854
  4. Details
NCT03428854 Clinical Trial

Adenomyosis: Genomic Mechanisms and Biological Response

Adenomyosis Clinical Trial

Official title:
Adenomyosis: Genomic Mechanisms and Biological Response

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT03428854
Other study ID # 0000
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date December 1, 2020
Est. completion date October 1, 2022

Study information
Verified date January 2021
Source University of Texas Southwestern Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.

Description:

Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date October 1, 2022
Est. primary completion date October 1, 2022
Accepts healthy volunteers
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Abnormal bleeding in the presence of Adenomyosis as demonstrated by MRI Exclusion Criteria: - Other causes of abnormal bleeding such as fibroids, endometrial polyps, malignancy - Presence of endometriosis

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• LNG-IUS
Levnorgestrel containing IUD

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
University of Texas Southwestern Medical Center

Outcome
Type Measure Description Time frame Safety issue
Primary Menstrual blood loss Pictorial blood loss assessment chart 12 months
Secondary Quality of Life SF-12 12 months
Secondary Pain Visual analog scale 12 months
See also
  Status Clinical Trial Phase
Completed NCT04665414 - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Recruiting NCT04209127 - Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis N/A
Completed NCT05751876 - Dienogest in Perimenopausal Women With Adenomyosis
Recruiting NCT01048931 - Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Phase 3
Active, not recruiting NCT06223464 - Evaluation of the Relationship Between Adenomyosis and Elastographic Properties of the Cervix
Completed NCT05419414 - The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis N/A
Recruiting NCT05152667 - Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin
Not yet recruiting NCT03654144 - Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis Phase 4
Completed NCT02192606 - Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? N/A
Completed NCT01992718 - What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography Early Phase 1
Recruiting NCT02495311 - The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
Recruiting NCT03742843 - A Multi-omics Study of Adenomyosis
Recruiting NCT04481321 - Clinical and Molecular Study of Endometriosis and Adenomyosis
Recruiting NCT04894292 - The Effect of Adenomoyosis on Pregnancy Outcomes
Completed NCT03520439 - Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis Phase 2/Phase 3
Recruiting NCT05937490 - Adenomyosis and ART Phase 4
Recruiting NCT06373822 - New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
Completed NCT01821001 - Vaginal Bromocriptine for Treatment of Adenomyosis Phase 1
Recruiting NCT04295109 - Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function N/A
Recruiting NCT04356664 - Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis Phase 2/Phase 3